CD40LG and Stroke: In this study, stroke infarct size was unaffected by treatment with low dose IgM‐IVIg (Figure S1), which is consistent with the use of low‐dose IVIg in replacing circulating antibody in immunosuppressed patients and not for its anti‐inflammatory properties.